ARTICLE | Clinical News
Jerini starts angioedema Phase II
February 11, 2003 8:00 AM UTC
Jerini (Berlin, Germany) began a Phase II trial of Icatibant in patients with acute attacks of angioedema. Icatibant is a selective peptidomimetic bradykinin BK 2 receptor antagonist licensed from Ave...